Economic Atlas
Companies/Fulgent Genetics, Inc.
Company profile

Fulgent Genetics, Inc.

NASDAQ: FLGT · Healthcare · Medical - Diagnostics & Research
PublicHQ El Monte, CA · Los AngelesCIK 0001674930Reports USD
#240 of 1,418 Healthcare companies by revenue60th-percentile growth
EA Score
68B
Revenue TTM
$320.3M
Rev growth YoY (TTM)
+9.5%
Net income (FY)
-$60.5M
Employees
1,315
as of 2026-08-11
Market cap
$541.3M
as of 2026-08-11

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$322.7M$322.7M2025
Net income-$60.5M-$60.5M2025
Operating income-$91.1M-$91.1M2025
Total assets$1.2B$1.2B2025
Liabilities$106.8M$106.8M2025
Equity$1.1B$1.1B2025

Revenue trend

FY2021 – FY2025 · USD
FY21
FY22
FY22
FY22
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Laboratory Services100%
By geography
US85%
Non-US7%
Other Countries4%
CHINA4%
The read

What is Fulgent Genetics, Inc.’s revenue?

Fulgent Genetics, Inc. booked $322.7M in FY2025 revenue, growing 14% year over year — faster than most Healthcare companies we track, at a -18.8% net margin.

Peers · Healthcare
TruBridge, Inc.75B+Castle Biosciences, Inc.70BTactile Systems Technology, Inc.83B+DocGo Inc.44DKnight Therapeutics Inc.77B+Eagle Pharmaceuticals, Inc.——
Neighbors
Los Angeles →
The Walt Disney Company$94.4B72BPublic Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68BLive Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D
Key facts
CEOMing Hsieh
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersEl Monte, CA
ExchangeNASDAQ: FLGT
Employees1,315
IPO date2016-09-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.